Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli.
about
Dysbiosis in inflammatory bowel diseasePathogenic role of the gut microbiota in gastrointestinal diseasesMechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont SelectionHLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic ratsA Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing SpondylitisThe intestinal microbiome in spondyloarthritisImpact of the gut microbiota on rodent models of human diseaseFucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's diseaseAn abundance of Escherichia coli is harbored by the mucosa-associated bacterial flora of interleukin-2-deficient mice.Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel diseaseGnotobiotic IL-10; NF-kappaB mice develop rapid and severe colitis following Campylobacter jejuni infection.Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota.Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel diseaseThe colitis-associated transcriptional profile of commensal Bacteroides thetaiotaomicron enhances adaptive immune responses to a bacterial antigenClinical aspects and pathophysiology of inflammatory bowel disease.Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus.Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes.Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel diseaseMicrobiota regulation of inflammatory bowel disease and colorectal cancer.Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria.Activation of RegIIIbeta/gamma and interferon gamma expression in the intestinal tract of SCID mice: an innate response to bacterial colonisation of the gut.The Mammalian Microbiome and Its Importance in Laboratory Animal Research.Colonic Lesions, Cytokine Profiles, and Gut Microbiota in Plasminogen-Deficient MiceDisease Severity and Immune Activity Relate to Distinct Interkingdom Gut Microbiome States in Ethnically Distinct Ulcerative Colitis PatientsSerum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progressionImmunogenetic phenotypes in inflammatory bowel disease.Treatment with a Monoclonal Anti-IL-12p40 Antibody Induces Substantial Gut Microbiota Changes in an Experimental Colitis Model.Toxoplasma gondii rhoptry 16 kinase promotes host resistance to oral infection and intestinal inflammation only in the context of the dense granule protein GRA15.Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women.Microbial and histopathologic considerations in the use of mouse models of inflammatory bowel diseases.HLA-B27 misfolding and spondyloarthropathies.Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice.Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice.Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats.Microbial sensing by the intestinal epithelium in the pathogenesis of inflammatory bowel disease.Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice.Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies.Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice.Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.
P2860
Q24685931-A5395023-195E-46C0-B7BE-BB765F2C9E31Q26749878-897D7511-D761-4E55-BE5E-8741C53871B4Q26774688-F9670B33-D334-4CB9-868F-5167FDAE4410Q27313830-DEE9D4F5-4E87-4DA9-B186-E64E26A16010Q28069331-C21D1547-D840-4884-9BA9-6260CD0353C0Q28080969-6A6A5831-BDCE-405E-8F62-5EECCD6C43BAQ28087215-966E6BB1-A7E5-441B-B35A-12040271556BQ29417151-4E674C43-08E1-491D-93B0-CF665A6EBB1AQ33200059-402BA6A1-BFD3-40A0-8802-5B82154F12E7Q33201542-82CA2D76-1B99-40A2-BADE-A599FC20329AQ33511448-38B92D86-4738-4F80-AFE1-24051F32234BQ33745764-4CA024A0-982B-44ED-8968-3AF3C8544681Q34006798-F0F005B4-30F4-4AB5-A522-302CE5701AF8Q34185267-30E1D135-33A4-4E9E-902C-F3E3C7EA317CQ34374507-562A09BC-F6F5-4104-90CB-2B761FC3EE21Q34487217-8E2D2612-D321-419A-ABE4-7CAD0D801EDFQ34549343-16A2DC45-F9E1-4D98-8EF0-8B06447B2F0FQ34668698-6616D734-2059-4F8C-9959-D310214D0116Q34775582-85025026-D4C9-4AAF-8217-31CA9F068609Q35000300-45051E8F-B82B-4FB4-B2B3-3D234D8BB527Q35140083-C04D8530-82CC-4130-ADE1-DE550972E01DQ35597375-AB91FD66-0E18-435A-973A-A87808A5E0D2Q35760610-515C791B-CE15-4526-A84B-CDB0FFF9F837Q35809949-97AB75CC-45DF-4271-B386-AB2E8A9E541FQ36105520-E4B0DA3D-579D-4F4A-A9EF-4BA8D7B23A11Q36484765-984617CF-6ECD-44BB-8E7F-51A0FC6A4835Q36506455-0D0ACE33-07C9-4A52-93C5-92386F5D312CQ36530839-D3F3CDD4-B595-4C21-A418-170D1A9D82A0Q36911407-39CD8BDB-2E2A-49F5-8286-815698FFFA8CQ37013125-93866B32-2A8D-4096-B28A-41D6AB3E991CQ37070484-5E15675E-39CC-428D-BF6D-6297E5CD970AQ37178385-433D89EB-F353-4354-B9DB-7F9793565108Q37394024-B9E0B084-C417-45BD-A873-A7464DEDDBEAQ39537971-43096802-F82C-4060-95DF-DF1E1BDA6690Q40833729-01CFFF6A-F322-4AAE-86AF-D7626E31D0D1Q41218016-5A3027CA-AFBF-40C3-91AE-62EB05067B83Q41395291-7A7A9DC4-D525-425E-996B-EE8D14CF4013Q42126037-B36BEEEC-E81B-4D22-8431-3382C8901258Q42128973-C1556C1F-533B-4892-9F85-2D3FDE07B495Q42151699-C70EBEF3-3967-45AA-BF3C-87B172CC2DE1
P2860
Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Differential induction of coli ...... vulgatus or Escherichia coli.
@ast
Differential induction of coli ...... vulgatus or Escherichia coli.
@en
Differential induction of coli ...... vulgatus or Escherichia coli.
@nl
type
label
Differential induction of coli ...... vulgatus or Escherichia coli.
@ast
Differential induction of coli ...... vulgatus or Escherichia coli.
@en
Differential induction of coli ...... vulgatus or Escherichia coli.
@nl
prefLabel
Differential induction of coli ...... vulgatus or Escherichia coli.
@ast
Differential induction of coli ...... vulgatus or Escherichia coli.
@en
Differential induction of coli ...... vulgatus or Escherichia coli.
@nl
P2093
P2860
P1476
Differential induction of coli ...... vulgatus or Escherichia coli.
@en
P2093
P2860
P304
P407
P577
1999-06-01T00:00:00Z